Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
Clinical trial NCT05203939 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05203939
- Sponsor
- Ocugen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2027-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.